These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22747840)

  • 1. Nutraceuticals and their preventive or potential therapeutic value in Parkinson's disease.
    Chao J; Leung Y; Wang M; Chang RC
    Nutr Rev; 2012 Jul; 70(7):373-86. PubMed ID: 22747840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of treatment of depression in assuring the most efficacious management of Parkinson's disease.
    Kaiser HE; Bodey B; Bodey B
    In Vivo; 2000; 14(3):457-62. PubMed ID: 10904882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic role of coenzyme Q(10) in Parkinson's disease.
    Shults CW
    Pharmacol Ther; 2005 Jul; 107(1):120-30. PubMed ID: 15963354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis.
    Henchcliffe C; Beal MF
    Nat Clin Pract Neurol; 2008 Nov; 4(11):600-9. PubMed ID: 18978800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: relevance to Parkinson's disease.
    Arduíno DM; Esteves AR; Cardoso SM; Oliveira CR
    Neurochem Int; 2009 Sep; 55(5):341-8. PubMed ID: 19375464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease.
    Calì T; Ottolini D; Brini M
    Biofactors; 2011; 37(3):228-40. PubMed ID: 21674642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease: mitochondrial molecular pathology, inflammation, statins, and therapeutic neuroprotective nutrition.
    Kones R
    Nutr Clin Pract; 2010 Aug; 25(4):371-89. PubMed ID: 20702843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norepinephrine: The redheaded stepchild of Parkinson's disease.
    Rommelfanger KS; Weinshenker D
    Biochem Pharmacol; 2007 Jul; 74(2):177-90. PubMed ID: 17416354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson's disease: a review.
    De Araújo DP; Lobato Rde F; Cavalcanti JR; Sampaio LR; Araújo PV; Silva MC; Neves KR; Fonteles MM; Sousa FC; Vasconcelos SM
    Int J Neurosci; 2011 Feb; 121(2):51-7. PubMed ID: 21126109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can we prevent Parkinson's and Alzheimer's disease?
    Kedar NP
    J Postgrad Med; 2003; 49(3):236-45. PubMed ID: 14597787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-DOPA: a scapegoat for accelerated neurodegeneration in Parkinson's disease?
    Lipski J; Nistico R; Berretta N; Guatteo E; Bernardi G; Mercuri NB
    Prog Neurobiol; 2011 Sep; 94(4):389-407. PubMed ID: 21723913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detrimental deletions: mitochondria, aging and Parkinson's disease.
    Biskup S; Moore DJ
    Bioessays; 2006 Oct; 28(10):963-7. PubMed ID: 16998822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal pathology in Parkinson's disease.
    Schulz JB; Falkenburger BH
    Cell Tissue Res; 2004 Oct; 318(1):135-47. PubMed ID: 15365812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early involvement of the cerebral cortex in Parkinson's disease: convergence of multiple metabolic defects.
    Ferrer I
    Prog Neurobiol; 2009 Jun; 88(2):89-103. PubMed ID: 19482226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidants, supplements, and Parkinson's disease.
    Weber CA; Ernst ME
    Ann Pharmacother; 2006 May; 40(5):935-8. PubMed ID: 16622156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Death in the substantia nigra: a motor tragedy.
    Esposito E; Di Matteo V; Di Giovanni G
    Expert Rev Neurother; 2007 Jun; 7(6):677-97. PubMed ID: 17563251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis and Parkinson's disease.
    Lev N; Melamed E; Offen D
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):245-50. PubMed ID: 12657363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Does early detection of non-motor symptoms facilitate early treatment of Parkinson's disease?].
    Hasegawa K
    Brain Nerve; 2012 Apr; 64(4):453-61. PubMed ID: 22481518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.